CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.3B
1-Year Est. Return 45.9%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+45.9%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.21B
AUM Growth
+$148M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
516
New
Increased
Reduced
Closed

Top Buys

1
+$6.89M
2
+$4.05M
3
+$4M
4
FUTU icon
Futu Holdings
FUTU
+$3.28M
5
AVGO icon
Broadcom
AVGO
+$3.25M

Top Sells

1
+$2.28M
2
+$2.13M
3
+$2.05M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$2.05M
5
TMUS icon
T-Mobile US
TMUS
+$2.03M

Sector Composition

1 Technology 39.61%
2 Healthcare 20.82%
3 Communication Services 12.95%
4 Consumer Discretionary 11.61%
5 Consumer Staples 3.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZLAB icon
301
Zai Lab
ZLAB
$2.02B
$284K 0.02%
8,380
-3,247
BCRX icon
302
BioCryst Pharmaceuticals
BCRX
$2.37B
$279K 0.02%
36,796
-5,231
VCEL icon
303
Vericel Corp
VCEL
$1.52B
$278K 0.02%
8,845
-1,266
HRMY icon
304
Harmony Biosciences
HRMY
$1.56B
$278K 0.02%
10,085
-1,448
IRTC icon
305
iRhythm Holdings
IRTC
$3.86B
$275K 0.02%
+1,600
HLT icon
306
Hilton Worldwide
HLT
$68.3B
$265K 0.02%
1,021
ABCL icon
307
AbCellera Biologics
ABCL
$1B
$263K 0.02%
52,381
-7,568
DSGN icon
308
Design Therapeutics
DSGN
$646M
$263K 0.02%
34,982
+23,580
HUM icon
309
Humana
HUM
$20.2B
$261K 0.02%
+1,000
AVDL
310
DELISTED
Avadel Pharmaceuticals
AVDL
$260K 0.02%
17,020
-2,410
GSK icon
311
GSK
GSK
$108B
$259K 0.02%
6,000
+5,662
JANX icon
312
Janux Therapeutics
JANX
$807M
$257K 0.02%
10,534
-1,351
IMCR icon
313
Immunocore
IMCR
$1.48B
$255K 0.02%
7,021
-961
AUPH icon
314
Aurinia Pharmaceuticals
AUPH
$1.87B
$255K 0.02%
23,073
-4,062
NVCR icon
315
NovoCure
NVCR
$1.23B
$253K 0.02%
19,597
-2,794
ALV icon
316
Autoliv
ALV
$7.63B
$247K 0.02%
2,000
NVAX icon
317
Novavax
NVAX
$1.33B
$247K 0.02%
28,470
-4,061
TXG icon
318
10x Genomics
TXG
$2.46B
$234K 0.02%
20,055
-2,258
XPEV icon
319
XPeng
XPEV
$16.1B
$234K 0.02%
10,000
-20,000
ARDX icon
320
Ardelyx
ARDX
$1.35B
$233K 0.02%
42,241
-5,812
SNDX icon
321
Syndax Pharmaceuticals
SNDX
$2.02B
$232K 0.02%
15,099
-2,183
XERS icon
322
Xeris Biopharma Holdings
XERS
$954M
$230K 0.02%
28,305
-3,862
GLUE icon
323
Monte Rosa Therapeutics
GLUE
$1.26B
$228K 0.02%
30,825
-1,529
STOK icon
324
Stoke Therapeutics
STOK
$1.91B
$226K 0.02%
9,605
-1,361
GMAB icon
325
Genmab
GMAB
$15.9B
$225K 0.02%
7,350
-11,071
11 12
13
14 15